Clal Insurance’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6M | Buy |
+325,000
| New | +$28.6M | 0.28% | 64 |
|
|
2020
Q1 | – | Sell |
-14,285
| Closed | -$222K | – | 135 |
|
|
2019
Q4 | $222K | Buy |
+14,285
| New | +$222K | 0.24% | 66 |
|
|
2016
Q3 | – | Sell |
-55,600
| Closed | -$3.26M | – | 110 |
|
|
2016
Q2 | $3.26M | Hold |
55,600
| – | – | 0.08% | 73 |
|
|
2016
Q1 | $3.2M | Sell |
55,600
-8,200
| -13% | -$472K | 0.09% | 66 |
|
|
2015
Q4 | $4.18M | Sell |
63,800
-32,400
| -34% | -$2.12M | 0.11% | 61 |
|
|
2015
Q3 | $6.06M | Buy |
96,200
+36,900
| +62% | +$2.32M | 0.16% | 58 |
|
|
2015
Q2 | $4.2M | Buy |
+59,300
| New | +$4.2M | 0.1% | 69 |
|
|
2015
Q1 | – | Sell |
-212,940
| Closed | -$13.7M | – | 133 |
|
|
2014
Q4 | $13.7M | Buy |
+212,940
| New | +$13.7M | 0.33% | 57 |
|